Kubota Pharmaceutical Holdings Co., Ltd. Logo

Kubota Pharmaceutical Holdings Co., Ltd.

A clinical-stage company developing drugs and devices for ophthalmic diseases.

4596 | T

Overview

Corporate Details

ISIN(s):
JP3266500002
LEI:
Country:
Japan
Address:
千代田区霞が関3丁目7番1号

Description

Kubota Pharmaceutical Holdings Co., Ltd., through its subsidiary Kubota Vision Inc., is a clinical-stage company dedicated to developing novel treatments for ophthalmic diseases. Its mission is to translate scientific innovation into a diverse portfolio of drugs and devices to preserve and restore vision for people worldwide. The company's development pipeline features emixustat hydrochloride, a therapeutic candidate for Stargardt disease. In the device segment, Kubota is commercializing Kubota Glass®, a wearable technology designed to manage myopia. The company focuses on creating solutions to address the root causes of blindness and vision impairment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-19 07:30
訂正有価証券届出書(組込方式)
Japanese 247.7 KB
2025-11-17 01:00
有価証券届出書(組込方式)
Japanese 351.3 KB
2025-08-14 08:30
確認書
Japanese 8.4 KB
2025-08-14 08:30
半期報告書-第11期(2025/01/01-2025/12/31)
Japanese 230.5 KB
2025-07-31 08:37
訂正臨時報告書
Japanese 35.5 KB
2025-07-16 08:30
臨時報告書
Japanese 40.1 KB
2025-06-30 08:37
訂正臨時報告書
Japanese 28.6 KB
2025-06-20 08:30
臨時報告書
Japanese 27.5 KB
2025-04-21 08:30
臨時報告書
Japanese 23.8 KB
2025-03-28 08:10
確認書
Japanese 8.4 KB
2025-03-28 08:09
有価証券報告書-第10期(2024/01/01-2024/12/31)
Japanese 945.2 KB
2025-03-28 08:09
内部統制報告書-第10期(2024/01/01-2024/12/31)
Japanese 22.6 KB
2024-08-20 08:11
有価証券届出書(組込方式)
Japanese 231.3 KB
2024-08-14 08:03
確認書
Japanese 8.5 KB
2024-08-14 08:02
半期報告書-第10期(2024/01/01-2024/12/31)
Japanese 208.9 KB

Automate Your Workflow. Get a real-time feed of all Kubota Pharmaceutical Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kubota Pharmaceutical Holdings Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kubota Pharmaceutical Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.